RIGImmune Announces Acquisition of Antiviral Company Subintro and Concurrent Financing by F-Prime Capital
Newly formed company founded by prominent Yale professors will advance development of novel RNA therapies…
Month: September 2022
Jasper Therapeutics Announces FDA Fast Track Designation for JSP191, a novel monoclonal antibody targeting CD117, in the treatment of patients with severe combined immunodeficiency (SCID) undergoing allogeneic hematopoietic stem cell transplant
JSP191 is currently being evaluated in four ongoing clinical studies in allogeneic hematopoietic stem cell…
IN8bio Partners with the Dunbar CAR T-Cell Program at the University of Louisville as the Manufacturing Center for INB-400
Facility team in the of the UofL Health – Brown Cancer Center GMP Manufacturing Facility…
Pharma Two B Presents Positive Efficacy and Safety Data of P2B001 from Phase 3 Trial at the MDS International Congress of Parkinson’s Disease and Movement Disorders®
P2B001 is a novel proprietary fixed-dose combination of extended-release (ER) formulations of low doses of…
Kymera Therapeutics Receives FDA Orphan Drug Designation for KT-333, a First-in-Class, Investigational STAT3 Degrader for the Treatment of Cutaneous T-Cell Lymphoma
Cutaneous T-Cell Lymphoma is the second orphan drug designation for KT-333 WATERTOWN, Mass., Sept. 15,…
Nabriva Therapeutics Announces Date of 1-for-25 Reverse Stock Split
DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 15, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc…
OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022 SIGNIFICANT STRATEGIC AND…
BioJiva Reports Results of Pilot Phase 2 Clinical Trial of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Signals of Clinical Benefit Detected in Small Phase 2 Study, Suggesting Potential to Show Statistically…
BVI Announces Certification for its Intraocular Lens Portfolio under the European Medical Device Regulation
WALTHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — BVI, a diversified global ophthalmic device company,…
Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
EBT-101 is an in vivo CRISPR-based therapeutic designed to remove HIV proviral DNA from affected…
Tonix Pharmaceuticals Announces Data Presentations Involving TNX-1500 (Fc-Modified Anti-CD40L mAb) for the Prevention of Rejection in Allograft and Xenograft Transplantation in Animal Models at the International Congress of The Transplantation Society (TTS 2022)
TNX-1500 Treatment Prevents Organ Rejection and Preserves Function for Both Allograft and Xenograft Transplants in…
Ocuphire Announces Upcoming Presentations at European Forum 2022, Eyecelerator@AAO 2022 and the American Academy of Ophthalmology 2022 Annual Meeting
FARMINGTON HILLS, Mich., Sept. 15, 2022 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
RIFF Cannabis Brand Launches ‘Drumsticks’
New Limited-Edition Infused Pre-Rolls Now Available Across Ontario, Canada TORONTO, Sept. 15, 2022 (GLOBE NEWSWIRE)…
Tiziana Life Sciences Announces Grant received by the Brigham and Women’s Hospital to Explore the Use of Intranasal anti-CD3 mAb in Amyotrophic Lateral Sclerosis
– Prestigious ALS Association grant awarded to BWH to study the utility of an intranasal…
Datawiza Integration with Microsoft 365 Brings MFA to Oracle Business Applications
Datawiza’s cloud-native access proxy enables multifactor authentication for Peoplesoft, Oracle E-Business Suite, JD Edwards and…
The First Layer 2 Scaling Solution for Solana Comes Out of Stealth
NEW YORK, NY, Sept. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Nitro, the first…
Fandifi Commences Marketing Preparations for Beta Launch
Vancouver, British Columbia–(Newsfile Corp. – September 15, 2022) – Fandifi Technology Corp. (CSE: FDM) (OTCQB:…
Ucore’s Rare Earth Separation Commercial Demonstration Plant On-Track for Q4-2022 Commissioning
Ucore’s rare earth separation commercial demonstration plant is designed to process: Tens of tonnes of…
Nova Mentis Completes Production of Psilocybin Microdose Capsules
Company Plans to Submit Clinical Trial Application in Canada Vancouver, British Columbia–(Newsfile Corp. – September…
Naturevan Launches Business Through Amazon
Toronto, Ontario–(Newsfile Corp. – September 15, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…